- Home
- IDYA vs QS Comparison
IDYA vs QS Comparison
Compare IDYA & QS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- QS
- Stock Information
- Founded
- IDYA 2015
- QS 2010
- Country
- IDYA United States
- QS United States
- Employees
- IDYA N/A
- QS N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- QS Auto Parts:O.E.M.
- Sector
- IDYA Health Care
- QS Consumer Discretionary
- Exchange
- IDYA Nasdaq
- QS Nasdaq
- Market Cap
- IDYA 2.0B
- QS 2.2B
- IPO Year
- IDYA 2019
- QS N/A
- Fundamental
- Price
- IDYA $21.67
- QS $4.30
- Analyst Decision
- IDYA Strong Buy
- QS Sell
- Analyst Count
- IDYA 12
- QS 7
- Target Price
- IDYA $54.27
- QS $5.19
- AVG Volume (30 Days)
- IDYA 1.2M
- QS 11.3M
- Earning Date
- IDYA 08-05-2025
- QS 07-23-2025
- Dividend Yield
- IDYA N/A
- QS N/A
- EPS Growth
- IDYA N/A
- QS N/A
- EPS
- IDYA N/A
- QS N/A
- Revenue
- IDYA $7,000,000.00
- QS N/A
- Revenue This Year
- IDYA $101.20
- QS N/A
- Revenue Next Year
- IDYA $286.70
- QS N/A
- P/E Ratio
- IDYA N/A
- QS N/A
- Revenue Growth
- IDYA N/A
- QS N/A
- 52 Week Low
- IDYA $13.45
- QS $3.40
- 52 Week High
- IDYA $44.42
- QS $9.52
- Technical
- Relative Strength Index (RSI)
- IDYA 58.21
- QS 51.78
- Support Level
- IDYA $21.09
- QS $4.21
- Resistance Level
- IDYA $22.50
- QS $4.50
- Average True Range (ATR)
- IDYA 0.97
- QS 0.22
- MACD
- IDYA -0.04
- QS 0.01
- Stochastic Oscillator
- IDYA 56.44
- QS 50.61
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
About QS QuantumScape Corporation
QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles and other applications. The company's solid-state lithium-metal battery technology is designed to offer greater energy density, faster charging, and enhanced safety. Its battery cells have none of the host materials used in conventional anodes.